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Abstract
Understanding HIV transmission dynamics is critical to estimating the potential population-wide impact of HIV prevention
and treatment interventions. We developed an individual-based simulation model of the heterosexual HIV epidemic in
South Africa and linked it to the previously published Cost-Effectiveness of Preventing AIDS Complications (CEPAC)
International Model, which simulates the natural history and treatment of HIV. In this new model, the CEPAC Dynamic
Model (CDM), the probability of HIV transmission per sexual encounter between short-term, long-term and commercial sex
worker partners depends upon the HIV RNA and disease stage of the infected partner, condom use, and the circumcision
status of the uninfected male partner. We included behavioral, demographic and biological values in the CDM and
calibrated to HIV prevalence in South Africa pre-antiretroviral therapy. Using a multi-step fitting procedure based on
Bayesian melding methodology, we performed 264,225 simulations of the HIV epidemic in South Africa and identified 3,750
parameter sets that created an epidemic and had behavioral characteristics representative of a South African population
pre-ART. Of these parameter sets, 564 contributed 90% of the likelihood weight to the fit, and closely reproduced the
UNAIDS HIV prevalence curve in South Africa from 1990–2002. The calibration was sensitive to changes in the rate of
formation of short-duration partnerships and to the partnership acquisition rate among high-risk individuals, both of which
impacted concurrency. Runs that closely fit to historical HIV prevalence reflect diverse ranges for individual parameter
values and predict a wide range of possible steady-state prevalence in the absence of interventions, illustrating the value of
the calibration procedure and utility of the model for evaluating interventions. This model, which includes detailed
behavioral patterns and HIV natural history, closely fits HIV prevalence estimates.
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Introduction
South Africa (SA) carries the heaviest burden of HIV disease in
the world, with 6.1 million people infected and HIV prevalence of
17.9 among adults aged 15–49 [1]. Heterosexual transmission of
HIV is the leading cause of new HIV infections among adults [2].
Simulation models can capture key features of HIV transmission
within a population using explicit assumptions about the timing of
infectiousness and the extent and distribution of sexual behavior
within the population. Such models can and have been used to
assess the likely impact of treatment and prevention interventions
[3,4].
HIV transmission dynamics, and the potential effect of
interventions on them, are driven by the natural history of
infection [5–7], heterogeneity in sexual behavior, assortativity of
selecting sexual partners, and partnership concurrency [8–14].
Although a number of ongoing community-based randomized
trials are assessing the impact of changing some of these factors on
HIV incidence and prevalence, HIV simulation models provide an
additional method to explore these questions in an effective and
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the impact of adjusting multiple interventions at once. Combining
the natural history of HIV dynamics and human behavior results
in complex models, and few systematic efforts have incorporated
both aspects into a single transmission model [15–22]. Models
incorporating these simultaneous processes, along with large
changes in infectiousness during HIV progression in an individual,
may give substantially different results from models that average
over or ignore heterogeneities in sexual behavior and infectivity
[6,23,24], in part because for HIV, changes in individual
infectiousness and epidemic growth both occur over a period of
several years.
For these reasons, we developed a single individual-based
simulation model of HIV transmission dynamics, the CEPAC
(Cost-Effectiveness of Preventing AIDS Complications) Dynamic
Model (hereafter called the CDM), which links to a previously
published disease model (CEPAC) and includes detailed sexual
mixing among heterosexuals. This model was calibrated, using a
fitting procedure based on a Bayesian Melding approach [25–29].
Methods
Model overview
The CDM is a stochastic, agent-based model designed to
simulate sexual transmission of HIV in a population. The agents in
the CDM are males or females who become sexually-active and
then form and dissolve sexual partnerships at rates dependent on
their sexual risk behavior (high- or low-risk) and commercial sex
worker (CSW) status. Individuals who become HIV-infected
during a sexual act with an HIV-infected partner progress through
stages of HIV infection via the CEPAC International Model
(hereafter called the Disease Model) [30–35], potentially trans-
mitting HIV to his/her partners and eventually dying of HIV
infection or other causes (Figure 1). The CDM captures the key
features of sexual mixing and human behavior that impact HIV
transmission, and links with the Disease Model to incorporate HIV
natural history (CD4 count, HIV RNA, development of oppor-
tunistic infections (OIs)), and mortality of HIV-infected and HIV-
uninfected individuals. The programming platform and compu-
tational performance of the CDM is outlined in Text S1.
The Disease Model is a state-transition model of HIV natural
history, which has been described elsewhere in detail [31–33,35].
In brief, disease progression in the Disease Model is characterized
as a sequence of monthly transitions from one ‘‘health state’’ to
another (Figure 1). Health states are defined as follows: primary
infection is the first three months post-infection, chronic infection
immediately follows primary infection and continues until the
individual’s CD4 count drops below 50/mm
3; late-stage infection
occurs when the individual’s CD4 drops below 50/mm
3. HIV
RNA is stochastically assigned by the disease model and
determines the monthly decline in CD4 count, which in turn
leads to increased risks of OIs and HIV-related mortality [36,37].
The basic partnership selection framework of the CDM is that
males choose females for various types of partnerships based on
the difference between both partners’ ages, current relationship
status, and behavioral risk (high- or low-risk) (Tables 1 and S1). In
the CDM, the probability that any act between an HIV-infected
and uninfected partner results in transmission depends on the
disease stage if the infectious partner is in primary or late-stage
infection and on HIV RNA if in chronic, condom use in that
sexual act, the protective efficacy of condoms, the circumcision
status of the uninfected male partner, and the protective efficacy of
circumcision (Text S2 and Table S1).
We modeled sexual acts using four types of partnerships: 1) A
steady partnership (similar to a marriage), defined as a main
partnership of long duration (Table S1) formed between a
sexually-active, single male and a sexually-active, single, non-
CSW female; 2) A regular partnership, defined as an ongoing
partnership of shorter duration (less than the duration of a steady
partnership, Table S1) formed between a sexually-active male and
a sexually-active, non-CSW female; 3) A casual partnership,
defined as one sexual act by a sexually-active male and sexually-
active, non-CSW female; and 4) A CSW partnership, defined as
one sexual act between a sexually-active male and CSW female
assumed to involve payment or exchange of goods or services for
sexual acts.
Dynamic Model Steps
Model initialization. We used the CDM to generate an
initial population, one individual at a time, using specified values
for population size, proportion male, proportion of males
circumcised, age of sexual debut, and proportion of females who
are CSW. The initial population was divided into nine age strata
based on user-specified proportions of the population in each age
range. Individuals younger than the user-defined age of first sex for
the CDM were classified as non-sexually-active. With fixed sex-
and CSW status-specific probabilities, sexually-active individuals
were assigned to be high-risk; otherwise they were low-risk. A
complete list of the CDM parameters used to describe population
characteristics, sexual partnership characteristics, partnership
selection, and probability of transmission is provided in Tables 1
and S1. In the CDM, each sexually-active male has a mean
partner acquisition rate for each partnership type. We allowed the
monthly mean partner acquisition rates for steady, regular and
casual partnerships to differ for high-risk males compared to low-
risk males by a high-risk multiplier, a parameter multiplied by
each of the four low-risk partner acquisition rates. Similarly, we
applied a CSW multiplier for high-risk compared to low-risk males
to the partner acquisition rate for CSW partnerships.
We ran the CDM for an initialization period of 50 years
(roughly 5 times the duration of a steady partnership in the model)
in the absence of HIV prior to time 0, so that the steady and
regular partnerships form and dissolve over the average lifespan of
individuals in the model, allowing for the distribution of these
Figure 1. General health states. When HIV-uninfected individuals (blue) in the CDM acquire HIV (red) the health state values are gathered from
the Disease Model. Individuals can die during any of the states depicted.
doi:10.1371/journal.pone.0098272.g001
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partnerships is described below (see Partnership updates). After the
50-year initialization period, hereafter referred to as time 0, the
CDM is seeded with HIV-infected individuals with a specified age,
gender, and CSW status (Table S1). The Disease Model assigns
these individuals an initial CD4 and HIV RNA.
Births. Each month, after deaths are tallied in the model, the
CDM generates births based on the population size and the
average birthrates for SA from 1985–2002 [38].
Monthly updates for individuals. Every month, the model
increases each individual’s age by one month. When an individual
reaches the age of sexual debut, age 17 (Table S1) [39–41], he/she
moves into the sexually-active, single pool and is classified as low-
or high-risk based on the gender- and CSW status-specific
probabilities used in initialization (Table 1). Individuals remain
in their assigned HIV-risk group or CSW for their lifetime. Newly
sexually-active males draw a monthly mean partner acquisition
rate for each of the four partnership types based on their risk
group (see Model initialization). All newly sexually-active females
have a defined probability of becoming a CSW.
The health status of prevalent HIV-infected individuals in the
CDM is updated every month with data gathered from the Disease
Model. Similarly, newly HIV-infected individuals acquire their
health status from the Disease Model beginning at the time of
infection. Death of HIV-infected and uninfected individuals
depends on age, gender and the probability of AIDS- and non-
AIDS-related causes of death [37,42–44]. Upon death, the
individual is removed from the active dynamic population and
the individual’s sexual partnerships end.
Partnership Updates. Partnerships are updated every
month allowing new partnerships to be formed and ongoing
partnerships to continue or dissolve, depending on the duration of
the given partnership type (Table S1). For each male, the number
of sexual acts and probability of condom use that month is
updated for each partnership type (Table S1).
For each partnership formed, the male selects a female partner
based on her partnership (single or non-single) and CSW status
applying the user-defined partner selection weights associated with
each partnership type (Table S1). Eligible age categories for the
female partners are based on the user-defined average age
difference for that partnership type. For steady, regular and casual
partnerships, once the age category has been selected, the male
selects the risk group (high or low) from which his partner is
drawn, based on the value of assortativeness (assort) parameter. A
male selects his partner randomly from his own risk group with a
probability of assort, and randomly from either risk group with a
probability of 1-assort. All females in the selected partnership
status, risk group, and age category have an equal probability of
being chosen by the male. The female selected by the male forms a
partnership of a defined type with that male. If a steady or regular
partnership is formed, the duration of that partnership is drawn
from a specified range for that partnership type (Table S1). If a
steady partnership is formed, the partnership status for each
partner is changed to non-single and the individuals cannot form
any other steady partnerships until the given steady partnership
has ended. The CDM tracks the type and number of partnerships
each individual forms each month.
Table 1. Prior ranges and posterior weighted means for model parameters varied in calibration of a dynamic model of HIV
transmission in South Africa.
Parameter Description
Prior Range for Fitting
Procedure Sources for Priors
Posterior Weighted
Mean
Ratio of Variance of Priors to
Variance of Posteriors
Chance of a female becoming a
CSW/Proportion CSW at baseline
0.01–0.04 [91] 0.021 1.00
Proportion of males in the HR group 0.07–0.4 [92–96] 0.21 1.29
Proportion of non-CSW females in the HR group 0.01–0.30 [91,94,96–99] 0.16 1.05
Monthly steady partnership acquisition
rate for low-risk males
0.002–0.008 * 0.004 2.31
Monthly regular partnership acquisition
rate for low-risk males
0.0001–0.10 ** 0.056 1.07
Monthly casual partnership acquisition
rate for low-risk males
0.0001–0.15 [100–103] 0.058 1.95
Number of acts per month per regular
partnership***
4–11 [65,66,99,104] 7.46 1.00
Monthly CSW partnership acquisition
rate for low-risk males
0.0001–0.10 **** 0.045 1.71
High-risk multiplier 1–10 MA 5.11 1.09
High-risk Multiplier CSW 30–100 MA 72.17 1.00
Partner acquisition multiplier while in steady
partnership for low-risk males
0–1 MA 0.39 1.03
Assortativeness parameter for steady,
regular and casual partnerships
0.2–0.8 MA 0.51 1.02
* Calculations based on the proportion HR male, the proportion SA male in a steady partnership, the duration of a steady partnership, and the HR multiplier.
** Calculations based on the range of the partner acquisition multiplier while in steady partnership for low-risk males, the proportion in a regular partnership and the HR
multiplier.
***This parameter follows a discrete uniform distribution.
**** Calculations based on proportion CSW, proportion of males who seek a CSW, proportion HR males who seek a CSW and number of acts per CSW.
HR: high-risk group, LR: low-risk group, CSW: commercial sex worker, SA: sexually-active, and MA: modeling assumption MA.
doi:10.1371/journal.pone.0098272.t001
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within a given month. However, males in steady partnerships may
have a decrease in their partner acquisition rates for forming other
partnerships, determined by a partner acquisition multiplier
(Table 1). We also allow females in the CDM to engage in
multiple partnerships within a month by using the partnership
selection weights (Table S1). These weights define the probability
that a male will select a single or non-single female to form a
steady, regular or casual partnership. For example, these weights
dictate that a male who is to form a regular partnership has a
higher chance of selecting a single female than of selecting a non-
single female. Also, in general, females in a steady partnership
have a decreased probability of being selected compared to single
females, and males can only select a CSW to engage in a CSW
partnership. To reflect the decrease in sexual activity as individuals
age, the partnership acquisition rates and sexual acts are adjusted
by a yearly age discounting factor, starting at the age of 50 (Table
S1).
In the model, once all males have formed all new partnerships
for the given month, all sexual acts between partners occur for that
month and the model determines whether HIV transmission has
occurred for each sexual act within each partnership (Text S2). For
each incident HIV infection, the initial HIV RNA and CD4 count
is obtained from the Disease Model using distributions for incident
cases. After all of the monthly transmission outcomes have been
determined, partnerships that have reached the end of their
duration, including any casual or CSW partnerships that were
formed in the same month, are ended. Upon dissolution of a
steady partnership, the individuals’ partnership status changes
back to single.
Internal validity of the Dynamic Model
Internal validation of the CDM was performed in a three step
process to evaluate the model’s structure and performance. First,
we evaluated the internal validity of the CDM by examining
randomly selected detailed reports or traces, which provide
monthly information on each partnership formed, the number of
acts per partnership, the health status and demographic charac-
teristics of the individual, and the number of new transmissions for
HIV-infected individuals.
Second, the HIV transmission dynamics were validated by
assessing the number of exposures that led to infections, stratified
by the HIV RNA of the infector. This was done by tallying the
number of unprotected sexual acts between an infected individual
and their uninfected partner (exposures) and the number of
infections, both stratified by the HIV RNA of the infector. We
were most interested in understanding the rate of transmission for
primary stage, late stage, very low viral load (HIV RNA,
500 copies/ml) and chronic infection with HIV RNA.
100,000 copies/ml.
Third, we examined the influence of each parameter to
determine if it had the expected impact on various model outputs,
such as the number of partners formed in a month, number of new
infections in a month, number of deaths, etc. We conducted
extreme sensitivity analyses to confirm consistent model behavior.
For example, we set the probability of transmission to 0 for all
HIV RNA strata and examined the model output to ensure that
no HIV transmission had taken place. We then set the probability
of transmission to 1 and confirmed that the model output showed
that all sexual acts between discordant partners resulted in HIV
transmission.
Choice of parameter values and ranges for a model of
South Africa
The parameter values related to disease progression for the
South African HIV epidemic have been published previously
[31,45]. For incident HIV cases, we reviewed the literature and
found the CD4 count of HIV-uninfected individuals ranged from
503 to 2051 cells/mm
3 [46–62], consistent with the mean CD4
count of 890 cells/mm
3 found by Phair [61] and 884 cells/mm
3
used by Granich [46,63]. We chose to use the value of 884 cells/
mm
3 as the initial CD4 count of incident HIV cases in the CDM
based on additional sensitivity analyses that analyzed the impact of
this parameter on life expectancy (See Text S3). The HIV RNA is
.100,000 copies/ml for the first three months post-infection. The
CD4 decline and distribution of HIV RNA after the first three
months is outlined in Table S2. Monthly mortality probabilities
are dependent on sex, age, the presence of acute and history of
OIs, and CD4 count [37,64]. Thus, the model includes both AIDS
and non-AIDS related causes of death.
Demographic and behavioral parameters representative of the
pre-antiretroviral therapy (ART) HIV epidemic in South Africa
starting in 1990 were obtained from the literature (Tables 1 and
S1). The data gathered for the input parameter values were
selected based on the study design, sample size and year the study
was performed. Sixty-four of the 76 behavioral parameters of the
model were given fixed values; these mainly represent selected
demographic parameters and the HIV RNA-dependent probabil-
ity of transmission including the initial age distribution across the
nine age strata and the initial number of incident HIV cases
stratified by age and gender (Table S1). The probability of
transmission per act was fixed at values ranging 0.0001 to 0.0023
for different ranges of HIV RNA during chronic infection, with
unique probabilities for primary (0.0082) and late-stage infection
(0.0036) (Table S1) [65–68].
After a complete literature search was conducted to gather the
most robust estimates for the behavioral parameters, there were 12
parameters in the model for which there were no or few direct
measurements in the literature (Table 1). Therefore, the values for
these 12 remaining parameters were varied across simulations in
the calibration exercises (see Dynamic Model Calibration below).
These parameters included, but are not limited to, the proportions
of individuals in different risk groups, partner acquisition rates in
each risk group for all partnership types, and the assortativeness of
mixing.
Dynamic Model Calibration
In brief, the CDM transforms the input, consisting of multiple
behavioral, disease-related, and demographic input parameters
(Tables 1, S1, and S2), into the output, HIV prevalence over a
given time period. We used a Bayesian Melding-like procedure
[25–28,69] to take prior information on the input parameters and
simulated behavioral properties of the population, then use priors
on the behavioral and epidemiologic outputs to exclude parameter
sets and combined it with a measure of how well the model output
(HIV prevalence) of each particular parameter value combination
fit annual estimates of HIV prevalence produced by UNAIDS
(Table S3) [1]. We began from a broad, multivariate uniform
distribution of values for 12 behavioral and demographic
parameters, which governed the sexual network formed by the
entire male and female sexually-active population (Table 1). While
many of the partnership formation rates and the proportions of
high- and low-risk individuals are not well-constrained by available
data, there are better data available for values of composite
quantities that depend on them, such as the proportion of adults of
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Therefore, we performed a three-step calibration procedure.
We began the calibration procedure producing a total of
264,225 parameter sets by randomly selecting values for each of
the 12 parameters from their respective prior uniform distributions
(Table 1). We ran the CDM once for each of the 264,225 different
input parameter sets, which consisted of both fixed and randomly
selected parameters. We then subjected the CDM output from
each parameter set to three phases of calibration (Text S4). During
Phase 1, we assigned likelihood weights of zero to parameter sets
for which the estimated sexual partnership prevalence and sexual
acts fell outside the pre-specified limits (Text S4.1 Phase 1, Table
S4). Formally, this is equivalent to having a multivariate uniform
prior on the composite quantities, as these limits reflected prior
information on behavioral quantities that are determined by
complex interactions of the partnership formation and dissolution
parameters that we specified in prior distributions (Table 1). The
Bayesian melding-like approach provides a rigorous framework for
reconciling the prior on the parameters with the prior on
composites of them, treating them as two sources of information
about the parameter values.
During Phase 2 of the calibration procedure, we assessed the
goodness of fit of the modeled HIV prevalence to annual
prevalence estimates from UNAIDS for the parameter sets that
remained with nonzero weight after Phase 1 (Text S4.2 Phase 2,
Table S3). We assigned each parameter set a weight proportional
to the pseudo-likelihood (Text S.4.3) that the parameter values
could produce the pre-ART HIV prevalence curve defined by the
UNAIDS estimates of HIV prevalence in South Africa [1,25–
28,70]. Parameter sets that failed to generate an epidemic, failed to
reach a prevalence ,0.005 after 38 years, were given zero weights
(0.005 was the prevalence in 1990 from the UNAIDS data).
During Phase 3 of the calibration procedure, we filtered the
parameter sets further to ensure face validity by conformance to
specified stratum-specific HIV incidence and prevalence, and
CSW behavioral parameters (Table S5) at the end of the
simulation (2002) (Text S4.3 Phase 3). Parameter sets failing this
phase had their weights set to zero. This calibration method was a
principled way to assign weights to combinations of parameter
values so that they are individually consistent with measurements
in the literature and that in combination produce modeled HIV
prevalence consistent with existing data. This method conceptually
combines random sampling methodologies (e.g. Latin Hypercube
sampling), focused on model inputs [71], with curve-fitting and
likelihood methodologies that focus on identifying parameter
values that produce well-fitting outputs [29,72–74].
Post-Calibration Analyses
To assess the impact of the 12 parameters varied in the analysis
on the HIV prevalence in each year from 1990–2002, we
calculated partial rank correlation coefficients (PRCC) for all 12
parameters with the predicted HIV prevalence at each year (Text
S5) [71]. Additionally, we generated two-dimensional heat plots
showing the location of high-weighted vs. low-weighted parameter
sets across each of the 132 ordered pairs of parameters (12*11), to
visually identify pairwise correlations between values of parame-
ters that produced well-fitting runs (Text S6). Histogram plots of
the weighted posterior distributions for the 12 parameters were
created to determine how the calibration restrictions influenced
the parameter sets that passed the calibration checks (Text S.6). To
provide a measure of how informative the calibration procedure
was for narrowing the prior ranges, we compared the posterior
means for each of the 12 parameters to its respective prior mean
and calculated the ratio between the variance of its prior
distribution and the variance of its posterior distribution.
Results
Model Validation Results
We examined randomly selected traces of individuals to
evaluate the internal consistency of the CDM. All the individuals
evaluated formed partnerships, had sexual acts, had updated
health status, aged, and died as defined and governed by the inputs
and design of the CDM. Figure 2 illustrates a trace of a high-risk
(Figure 2A) and low-risk (Figure 2B) male from just prior to
infection until death. These traces provide detail on all sexual
partnerships and potential transmissions due to partnerships with
the selected male using the best-fitting parameter set (see below).
The plot of the high-risk male (Figure 2A), shows the
partnerships that individual had each month from roughly one
year prior to infection until his death at age 37 (8.4 years after
infection). Throughout the course of his entire life, this male
formed 335 CSW, 17 casual, 65 regular and 3 steady partnerships.
A regular partner infected this male (represented by a large purple
star) when he was 29 years of age. After infection (vertical red line),
this male infected two regular partners during his acute infection,
two regular partners during chronic infection and one steady and
one regular partner during late-stage infection (represented by the
purple symbols). This male’s behavior is consistent with model
input parameters and the literature for high-risk males (Table 1).
The plot of the low-risk male (Figure 2B) shows this male’s
partnerships from roughly one year prior to infection by a steady
partner at 32 years of age until death at the age of 41, after being
infected with HIV for 9 years. This male did not infect any
partners after his own infection. Throughout the course of his
entire life, he formed 3 CSW, 4 casual, 10 regular and 1 steady
partnerships.
To further examine the connection between the disease stage
and HIV RNA strata and the probability of transmission per
sexual act, we examined model output to determine the
percentage of acts that resulted in transmission to an uninfected
partner. These percentages were stratified by the HIV RNA
bucket or disease status (primary or late-stage infection) of the HIV
infected partner. A total of 0.76% of all sexual acts with an HIV-
infected partner in primary stage resulted in infection, 0.24% of
acts with an HIV-infected partner who had an HIV RNA .
100,000 copies/ml in chronic stage infection resulted in infection,
and 0.36% of acts with an HIV-infected partner with late-stage
infection resulted in infection. Only 0.01% of acts with an HIV-
infected individual with HIV RNA,500 copies/ml resulted in
transmission to an uninfected partner. These numbers closely
approximate the transmission probabilities designated in the
model input, as expected (Table S1).
Calibration results
Of the original randomly selected 264,225 parameter sets,
32,769 runs (12.4%) passed Phase 1, 29,544 parameter sets
(11.2%) passed Phase 2, and 3,750 parameter sets (1.4%) passed
Phase 3 calibration (Figure S1). Likelihood weights ranging from
near 0 to 0.006 were assigned to each of the 3,750 simulations
based on its predicted HIV prevalence’s pseudo-likelihood of fit to
the UNAIDS HIV prevalence in South Africa from 1990–2002
[1,70]. The parameter sets that contributed to the top 90% of the
likelihood weight were selected from these 3,750 simulations.
These 564 runs closely follow the prevalence values from 1990–
2002 from South Africa (Figure 3) [1,70] and then take various
trajectories after 2002. A cumulative distribution of the weights
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with sigma =1 corresponds to the analyses described here in the
main text.
The posterior distributions for the 12 variables varied in the
fitting procedures are summarized in Table 1. The posterior mean
value for most parameters was close to its respective prior mean.
While the posterior variance was reduced for all parameters, the
ratio between the variance of the prior and the variance of the
posterior for the partnership acquisition rates and the proportion
of the population defined to be high risk were the largest,
Figure 2. Trace plot of a selected high-risk and low-risk male. In this figure, each month is represented on the horizontal axis with multiple
partners per month plotted vertically. Partnership types are represented as follows: & for steady partnerships,N for regular partnerships, m for casual
partnerships, and X for CSW partnership. A blue symbol represents an HIV-uninfected female partner, a purple symbol a female partner that becomes
HIV-infected that month and a red symbol a female partner who is previously HIV-infected. The duration of steady and regular partnerships are
represented by a line; if that partner acquires HIV during the partnership, the time of HIV acquisition is represented by a purple symbol and a change
in color of the line from green to red. The stage of HIV disease is depicted by the graph fill color, with green representing HIV-uninfected, purple
primary infection, red chronic infection and yellow late-stage infection. This male depicted in Panel A is a typical high-risk male and in Panel B a
typical low-risk male.
doi:10.1371/journal.pone.0098272.g002
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(Table 1). This indicates that these parameter values were most
constrained by this fitting procedure relative to their prior
distributions.
Despite substantial noise in the PRCC values prior to 1994, the
CSW acquisition rate and the CSW multiplier showed a positive
correlation with HIV prevalence at the beginning of the epidemic
(Figure 4). After 1994, parameters that influence short-term
(regular) partnerships (regular partnership acquisition rate, high-
risk multiplier, number of acts per regular partnership per month,
and proportion of males in the high-risk group) correlated strongly
and positively with HIV prevalence. The pairwise heat plots
(Figure S4) show that well-fitting values for each of these 4
parameters are negatively correlated with well-fitting values for the
remaining influential parameters, reflecting their importance in
determining prevalence and therefore fit to UNAIDS data. The
PRCC values calculated for the proportion of the population with
greater than 2 partnerships in the last month of 1990 (an estimate
of concurrency) showed that having multiple partners positively
influences the HIV prevalence for the years after 1994 (Figure S5).
We also plotted the weighted average HIV prevalence curves over
time stratified by age and gender (Figure S6) to confirm that our
model is able to capture the difference in prevalence expected in
males and females of different ages.
Discussion
Understanding the dynamics of HIV transmission in South
Africa is critical to determining the potential effect of interventions
on the epidemic. This report provides a detailed description of the
CEPAC Dynamic Model, which generates HIV prevalence trends
over time in South Africa, based on a detailed model of the natural
history of HIV infection (CEPAC). The CDM accounts for
changing transmissibility over the course of HIV infection. It also
incorporates sexual mixing that, while necessarily simplified from
reality, incorporates known features of sexual behavior, such as
heterogeneous individuals who differ in their propensity to form
different types of partnerships with different durations, stochastic
variation across sexual acts, the use of condoms, and possible
assortativeness in partner choice. The availability of a detailed
HIV infection natural history model for each infected individual,
together with these forms of heterogeneity, necessitated the
development of a stochastic, agent-based model. Models that
include such details are parameter-rich, and the parameter values
often are not directly measured in epidemiological and behavioral
studies. To address these challenges, we used a Bayesian-melding-
like procedure to allow for a principled way for combining prior
information on demographic and behavioral parameters - both
elementary quantities (e.g. rates of partnership formation) in the
model, and restrictions on the composites of these quantities (e.g.
prevalence of various partnership types at equilibrium before the
appearance of HIV) - with HIV prevalence data in South Africa
from 1990 to 2002 [1,70].
This calibration approach incorporates prior distributions on
model inputs, and estimates posterior distributions based on the fit
of model outputs to prevalence data (Phase 2 calibration, Figure 3)
and has many similarities with the Bayesian melding methodology
described by others [25–28,69], in that it also incorporated
restrictions on certain behavioral properties of the population that
were composite functions of the input parameters (Phase 1
calibration, Table S4), and on stratum-specific incidence and
prevalence at the end of the model run, year 2002 (Phase 3
calibration, Table S5). We also noted in preliminary analyses that
due to seeding of the epidemic with varying numbers of HIV-
infected individuals, there was considerable stochastic variation in
when the epidemic ‘‘took off’’, even for a fixed parameter set, but
once the epidemic exceeded a certain prevalence, repeated runs
with the same parameter set gave very similar prevalence curves.
Figure 3. HIV epidemic curves from the fitting procedures. This graph depicts that HIV epidemic curves generated by the CDM, from the
parameter sets that contribute the top 90% of the likelihood weight, closely represent the HIV prevalence in South Africa from 1990–2002 (large black
stars, Table S3) [1,70]. The estimated ranges for the South African prevalence from 1990–2002 for the UNAIDS data were plotted using small black
stars.
doi:10.1371/journal.pone.0098272.g003
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transmission models [75] and are essentially a reflection of the law
of large numbers. For this reason, we did not specify a time in the
model corresponding to a particular year a priori. Rather, in the
Phase 2 calibration step, we ‘‘slid’’ the model outputs along the
UNAIDS prevalence curve to identify the model year correspond-
ing to 1990 that gave the best fit of the data to the entire
prevalence curve. Because the UNAIDS estimates contain only
high and low estimates for annual prevalence, we were forced to
make assumptions to translate prevalence values in the model into
pseudo-likelihood weights. Despite these elaborations, each step of
the approach we took was guided by the concepts of Bayesian
melding.
With a complex, highly parameterized model of this sort, it is
possible that very good fits to the data can be obtained with a
variety of different sets of parameter values. Moreover, two
parameter sets giving indistinguishable fits to the data may imply
quite different trajectories for the epidemic in years after the
period used to fit the model, and may imply very different impacts
of proposed interventions, such as treatment or prevention
Figure 4. Partial rank correlation coefficients of varied parameters and HIV prevalence over time. This illustrates the relationship of each
of the varied parameters with the main outcome of interest, HIV prevalence in the sexually-active population from 1990–2002. The partial rank
correlation coefficient (PRCC), calculated from all runs passing the first phase of calibration, is plotted for each year between1990 and 2002. (LR: Low-
risk; HR- High-risk; CSW- Commercial Sex Worker).
doi:10.1371/journal.pone.0098272.g004
Development and Calibration of a Dynamic HIV Model
PLOS ONE | www.plosone.org 8 May 2014 | Volume 9 | Issue 5 | e98272interventions. Indeed, in our model, the top fitting parameter sets
produce long-term dynamics that are variable in their trajectory
after 2002, in the counterfactual situation of no antiretroviral
therapy introduction (Figure 3). This suggests that the effort
involved in calibration of a complex model should pay off in the
ability to consider alternative hypotheses (i.e. alternative param-
eter sets) for how the epidemic reached its state in 2002, which
may have different implications for the effectiveness and cost-
effectiveness of different interventions post-2002. In future work,
we will use the weights from these simulations to provide weighted
estimates of intervention effects, reflecting these alternative
possibilities for the behavioral and demographic parameters
underlying the observed epidemic.
In this calibration study, we were able to assess the effects of
particular parameters on the dynamics of the epidemic in a time-
specific way [76]. The HIV prevalence prior to 1994 is most
highly correlated with dynamics related to CSW partnerships. As
the epidemic matures, the impact of CSW behavior becomes less
important to the increase in prevalence than the parameters that
influence short-term partnership dynamics. In the later part of the
epidemic, regular partnership acquisition for low-risk males, the
high-risk multiplier, the number of sexual acts per regular
partnership per month, and the proportion of males who are in
the high-risk group all have a positive association with HIV
prevalence. Since these parameters influence the levels of number
of individuals having more than one partnership in a single month
in the CDM, it appears that multiple partnerships in a month,
which is a proxy for concurrency, may be important to the
transmission and spread of HIV in South Africa. As noted, the
PRCC between the parameters and prevalence also indicate that a
small core group of high-risk females and CSW is necessary to
create early epidemic growth in our model. The smaller the group
of high-risk individuals or CSWs, the higher the prevalence,
indicating concurrency is essential to increasing prevalence in our
model dynamics. This can also be seen in the PRCC relating more
than one partnership in a single month and HIV prevalence over
time (Figure S5).
This newly developed CDM includes extensive detail on sexual
behavior, HIV infectivity, and HIV disease progression. A number
of mathematical models have been developed that incorporate the
potential effects of HIV prevention interventions in resource-
limited settings [15–17,63,77–85]. While each of these models has
its own strengths, the CDM builds on their foundation by
simultaneously including important biological and behavioral
characteristics of HIV transmission. The CDM’s link to the
Disease model provides a unique opportunity to provide detailed
and extensive cost-effectiveness estimates for a number of
interventions. Additionally, the test-and-treat pathway in the
Disease Model would allow for a thorough examination of the
HIV testing cascade and understanding the effects of behavior on
this cascade for future analyses [86].
There are several limitations to the model. The CDM does not
include the transmission of other sexually transmitted infections
and their potential impact on HIV transmission. This may cause
the CDM to underestimate the transmission of HIV in a
population. However, the per-act transmission rates in the model
were derived from cohorts that include patients co-infected with
other sexually transmitted infections. In the CDM, CSWs only
form CSW partnerships and therefore cannot have steady, regular
or casual partnerships. Also, the CDM does not account for in-
and-out-migration, which would allow for HIV-infected individ-
uals to enter or exit the population. Migration could also allow
heterogeneous mixing beyond the risk group stratification. In
addition, the behavioral inputs are not varied over time. It is likely
that over the thirteen-year horizon of the CDM model simulation
there have been changes in sexual behaviors in South Africa.
Finally, the CDM does not include mother-to-child transmission,
so new births are assumed to be HIV-uninfected. Given the time
frame covered by this current calibration (1990–2002), the limited
access to ART among perinatally infected children in South Africa
[87], and their short survival, perinatally-infected children will
have a limited impact on the projections. However, as access to
ART increases among these children, both their survival [88,89]
and sexual initiation [90] will need to be incorporated into the
CDM.
Further, the analysis of complex individual-based simulation
models is difficult within reasonable computing constraints and
memory restrictions. For example, we are not able to guarantee
that we spanned the entire parameter space in our random
generation of parameter sets. We attempted to minimize the
possibility of important dynamics outside of the parameter ranges
used through extensive sensitivity analyses and mock calibrations.
Many of our methods of summarizing relevant output are also
limited. For example, the correlation plots represent the correla-
tion between only two parameters at one time and not all 12.
Therefore, while the noted correlations between two parameters
have been observed, there may be other correlations that depend
on 3- or more-way combinations of parameters that are not readily
visualized in these plots. Finally, we limited the number of outputs
collected from the model due to memory and computational run-
time constraints.
Despite these limitations, the CDM incorporates many of the
details found in previously published models into a single model
for use in cost-effectiveness analyses [63,84]. This model will be
extended into the post-ART years of the HIV epidemic in South
Africa; with this capability, the effect of both behavioral and
treatment interventions can be assessed. Combined with rigorous
literature and other data searches and a multi-step calibration
procedure that incorporates information on both the behavior and
biology of HIV transmission, the CDM stands as one of the most
detailed models in the HIV transmission literature.
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Figure S1 Cascade of parameter sets through the three
stages of calibration. Beginning with 264,225 randomly
chosen parameter sets, each parameter set was run through the
model and exposed to three sets of restrictions to determine the
runs that were most realistic in terms of sexual behavior and HIV
prevalence predictions. A total of 3,750 runs passed all calibration
restrictions and will be used in all future model analyses.
(PDF)
Figure S2 Cumulative runs vs. cumulative weight for
runs passing the calibration procedure. This histogram
depicts the cumulative distributions of weights (for a variety of
sigma values) assigned to the 3,750 runs that passed the calibration
procedure. The curve with sigma=1 corresponds to the analyses
described in the main text. The cut off (sigma=1) for the 564 runs
contributing to the top 90% of the weight is denoted by a red line.
As noted from the figure, as sigma increases the number of runs
that contribute to the top 90% of the weight to fit increases and the
variance in the weights increases as well.
(PDF)
Figure S3 Posterior distributions for each parameter
varied in the calibration procedure. Each histogram (A–L)
represents the posterior distribution for each of the parameters
varied in the calibration procedure with each of the bars
representing the summed weight of the runs in that parameter
value bin. The panels are as follows: A. Assortativity (Assort); B.
Number of sexual acts per regular partnership per month
(RegActs); C. Chance of a female becoming a CSW (Chan-
ceCSW); D. Proportion of males in HR group (PropHRMale); E.
Proportion of non-CSW females in HR group (PropHRFemale);
F. Partnership acquisition rate multiplier (EpsilonLR); G. HR
multiplier (HRMult); H. CSW multiplier (CSWMult); I. Monthly
acquisition rate for steady partnerships for LR males (AqRateSt-
dyLR); J. Monthly acquisition rate for regular partnerships for LR
males (AqRateRegLR); K. Monthly acquisition rate for casual
partnerships for LR males (AqRateCasLR); and L. Monthly
acquisition rate for CSW partnerships for LR males (AqRa-
teCSWLR).
(PDF)
Figure S4 Two-dimensional plots of model fit. On each
plot two CDM input parameters are varied, one on the x-axis and
the other on the y-axis. A point was generated for each
combination of the two parameter values that were part of one
of the 3,750 parameter sets created in the fitting procedures. The
color of each of these points represents the weight contribution for
the plotted CDM model simulation with red representing
parameter sets that contribute the top 90% of the weight and
cyan representing parameter sets that contribute the bottom 10%
of the weight. The plots represent the correlation between every
parameter varied in the fitting procedures. The figure abbrevia-
tions are as follows: high-risk multiplier (HRMult), the CSW-risk
multiplier (CSWmult), assortativeness parameter (Assort), propor-
tion of males in the high-risk group (PropHRMale), proportion of
females in the high-risk group (PropHRFemale), partner acquisi-
tion rate multiplier while in steady partnership (EpsilonLR),
monthly partner acquisition rate for a steady partnership among
low-risk males (AqRateStdyLR), monthly partner acquisition rate
for a regular partnership among low-risk males (AqRateRegLR),
monthly partner acquisition rate for a casual partnership among
low-risk males (AqRateCasLR), monthly partner acquisition rate
for a CSW encounter among low-risk males (AqRateCSWLR),
chance of a female becoming a CSW (P(CSWF)), and number of
acts per regular partnership per month among low and high-risk
males (RegActs). The panels are as follows: A. The correlation
between the monthly partner acquisition rate for a regular
partnership among low-risk males (AqRateRegLR) and the 12
varied parameters; B. The correlation between the high-risk
multiplier (HRMult) and the 12 varied parameters; C. The
correlation between the proportion of males in the high-risk group
(PropHRMale) and the 12 varied parameters; and D, The
correlation between the number of acts per regular partnership
per month among low and high-risk males (RegActs) and the 12
varied parameters. We have added random jitter around each
discrete value for RegActs so that one can see points on the plot.
(PDF)
Figure S5 Partial rank correlation coefficients of con-
currency in 1990 and HIV prevalence over time. This
graph illustrates the relationship between the proportion of the
population with greater than 2 partnerships in the last month of
1990 and the main outcome of interest, HIV prevalence in the
sexually active population from 1990–2002. The partial rank
correlation coefficient (PRCC) is plotted for each year between
1990–2002. The PRCC summarizes the impact of concurrency on
the HIV prevalence in that year. A positive PRCC indicates that
the HIV prevalence is positively correlated with concurrency (and
inversely so for a negative PRCC). Despite a great deal of noise in
the years prior to 1994, concurrency (defined as having 2 or more
partners in the last month of 1990) positively influences the HIV
prevalence for years after 1994.
(TIFF)
Figure S6 The CDM predicted HIV prevalence in South
Africa from 1990–2002 stratified by age and gender.
These graphs depict the weighted average of the HIV epidemic
curves generated by the CDM, from the parameter sets that
contribute the top 90% of the likelihood weight, stratified by
gender and age. The panels are as follows: A. Depicts the weighted
average HIV prevalence for males and females; B. Depicts the
weighted average HIV prevalence for males stratified by the 8 age
buckets modeled in the CDM; C. Depicts the weighted average
HIV prevalence for females stratified by the 8 age buckets
modeled in the CDM.
(PDF)
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